Skip to content

Drugs Used In Opioid Dependence Response Metabolism Pk Cn236521

Published: July 22, 2026Updated: August 20, 2026

This refers to how genetic factors influence the body's processing of medications used to treat opioid dependence. Individual variations can affect how well treatments like methadone work. Healthcare providers monitor response and may adjust dosing to ensure effective treatment.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
mild
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Fatigue or weight changes

(metabolic)

Mild symptoms that may not significantly impact daily life.

Frequency: Common at all stages

Nausea

(gastrointestinal)

Headache

(neurological)

Constipation

(gastrointestinal)

Drowsiness

(neurological)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Buprenorphine pharmacokinetic-guided dosing

Dosing adjustment of buprenorphine based on individual metabolic capacity to optimize opioid dependence treatment outcomes. CYP3A4 and other enzyme activity affects drug levels and treatment efficacy. May involve split dosing or adjusted intervals.

medication
2

Healthy lifestyle changes and stress management

Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.

lifestyle
3

Methadone metabolism assessment

Evaluation of methadone pharmacokinetics considering genetic variations in drug-metabolizing enzymes. Methadone has highly variable metabolism requiring individualized dosing strategies. Monitoring for QT prolongation is essential in all patients.

medication

Additional treatment options

Therapeutic drug monitoring for opioid dependence medications

Regular plasma level assessments of opioid dependence treatments to maintain therapeutic concentrations. Helps identify poor metabolizers requiring dose reduction or ultrarapid metabolizers needing frequency adjustments. Used in combination with clinical assessment.

monitoring

Integrated behavioral support with PK considerations

Combining psychological interventions with pharmacokinetic monitoring to address both physiological and psychological aspects of opioid dependence. Ensures medication efficacy while supporting recovery. Cognitive behavioral therapy complements medication management.

psychological

Naltrexone formulation selection based on metabolism

Selection between oral naltrexone and extended-release injectable formulations based on metabolic profile. Oral formulation requires robust hepatic metabolism while injectable avoids first-pass metabolism. Genetic testing can inform the choice.

procedure

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Drugs Used In Opioid Dependence Response Metabolism Pk Cn236521?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Substance Abuse and Mental Health Services Administration. Medications for Opioid Use Disorder Treatment Guidelines. J Addict Med. 2020.

guideline2020
2

Mattick RP, Breen C, Kimber J, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2014.

review2014
3

Tanum L, Solli KK, Latif ZE, et al. Effectiveness of Injectable Extended-Release Naltrexone vs Daily Buprenorphine-Naloxone. JAMA Psychiatry. 2017.

clinical_trial2017
4

Whelan PJ, Rimes-Troud 2, Cochrane J. Pharmacokinetic Interactions in Opioid Agonist Therapy: A Systematic Review and Meta-Analysis. Addiction. 2022.

meta_analysis2022

Medication Comparisons

Compare medications used to treat Drugs Used In Opioid Dependence Response Metabolism Pk Cn236521. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy